Provider of life science and molecular diagnostic products Affymetrix Inc.AFFX recently inked a partnership with advanced tissue technologies company - Reveal Biosciences. The collaboration will ...

Of late, Affymetrix Inc. AFFX has been scaling newer heights across all its business segments. Over the past few months, the company has won. Affymetrix Poised on Strategic Deals & Key Product ...

Affymetrix Inc. and Luminex Corporation have announced a distribution agreement under which eBioscience, a business unit of Affymetrix, will sell Luminex’s MAGPIX®, Luminex® 200™ and FLEXMAP 3D® ...

Affymetrix will sell the Luminex instruments together with ProcartaPlex ® multiplexed immunoassays and QuantiGene ® Plex multiplexed quantitative gene expression assays, offering complete ...

Affymetrix has announced the extension of its QuantiGene® Singleplex Assay for PCR-free gene expression measurement to include a 384-well format that is easily automatable for high-throughput compound ...

Samples were then provided to Affymetrix (Santa Clara, CA) for further analysis. gDNA samples were run at Affymetrix laboratories on the CytoScan Dx Assay, and results were provided to an ...

CA-based Affymetrix Inc. (AFFX) and scientific software company, BioDiscovery Inc., together launched an analysis software solution for cancer research – Nexus Copy Number. Nexus Copy Number is ...

Affymetrix Inc. AFFX said the U.S. Food and Drug Administration gave the medical technology company approval to market its procedure to help diagnose disabilities in ... The CytoScan DX Assay, ...

The FDA clears a first-of-a-kind blood test, developed by Affymetrix (AFFX-0.3%), that can help predict intellectual disabilities in infants by analyzing their genetic code. The CytoScan Dx Assay ...

Affymetrix Launches New OncoScan™ FFPE Assay Kit Breakthrough assay provides genome wide solid tumor copy number analysis in only 48 hours from only 80ng input DNA SANTA CLARA, Calif.--(BUSINESS ...